Top Markets
#1 CoW Protocol CoW Protocol +62.99%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +34.79%
#5 Walrus Walrus +26.86%
#6 Cysic Cysic +18.33%
#7 Humanity Humanity +17.83%
#8 Tutorial Tutorial +16.94%
#9 The Black Bull The Black Bull +16.75%
#10 Fabric Protocol Fabric Protocol +16.46%
Coin of the day
CoW Protocol CoW Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Norris Medicines Limited Norris Medicines Limited

Norris Medicines Limited

NORRIS
Rank in Stocks #37398
Norris Medicines Ltd. focuses on the development and production of... Norris Medicines Ltd. focuses on the development and production of pharmaceutical compounds, medicinal chemicals, and botanical extracts. Their diverse product range addresses various health concerns, encompassing categories like antibiotics, anti-inflammatory agents, anti-emetics, nutritional supplements, cough and cold remedies, dermatological and allergy treatments, anti-malarial drugs, and medications for diabetic and cardiac conditions. The company, which established its operations in 1990, is based in Ankleshwar, India.
Share Price
$0.17547045
Last synced: 2026-08-14
Market Cap
$1.75M
Change (1 day)
-2.51%
Change (1 year)
-10.85%
Country
IN
Trade Norris Medicines Limited (NORRIS)

Category

Healthcare
Number of shares outstanding for Norris Medicines Limited (NORRIS)
Number of shares outstanding as of August 2026: 0
According to Norris Medicines Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Norris Medicines Limited (NORRIS) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 445.06M -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 105.38M -
US